THE INVENTION RELATES TO A POLYMERIC, NON-CODING NUCLEIC ACID MOLECULE FOR MODULATION OF THE ACTIVITY OF THE HUMAN AND ANIMAL IMMUNE SYSTEM AS WELL AS A METHOD FOR THE MANUFACTURE THEREOF AND A VACCINE, COMPRISING THE POLYMERIC, NON-CODING NUCLEIC ACID MOLECULE, WHEREIN POLYMERIC, NON-CODING NUCLEIC ACID MOLECULES MAY BE UNDERSTOOD AS NON-CODING NUCLEIC ACID MOLECULES, COMPRISING AT LEAST FOUR COVALENTLY BOUND MOLECULES (TETRAMER) OR ARE ASSEMBLIES OF MORE NON-CODING NUCLEIC ACID MOLECULES (HIGH MOLECULAR POLYMERS) WHICH ARE COVALENTLY BOUND TO EACH OTHER.